nal of Cerebral Blood Flow and Metabolism (Murphy et aI., 1999) . The current review addresses the evidence for mitochondrial failure in induction of neuronal death or dysfunction in ischemiaireperfusion injury as well as in chronic forms of neurodegeneration including Alzhei mer's disease (AD), Parkinson's disease (PD), amyotro phic lateral sclerosis (ALS), and Huntington's disease (HD).
MITOCHONDRIAL INVOLVEMENT IN

ISCHEMIC NEURODEGENERA TION
Substantial evidence indicates that mitochondrial dys function plays an important role in the pathophysiologic mechanism of acute neurodegeneration caused by trauma, stroke, and cardiac arrest (Hillered, 1986; Rosen thal and Fiskum, 1990; Sims and Zaidan, 1995 for re view) . Neuronal death in vivo typically is heterogeneous and exhibits morphologic characteristics that represent a continuum between necrosis and apoptosis (Portera Cailliau et aI., 1997; MacManus and Linnik, 1997) . Rapid ischemic necrosis is primarily the result of anaero bic inactivation of mitochondrial oxidative phosphoryla tion, subsequent cellular deenergization, termination of active transport processes, and massive cellular influx of Ca 2 + and other ions from activation of voltage-dependent ion channels and ligand-dependent channels (e.g., gluta mate receptor operated channels) (Siesjo, 1992; Choi and Rothman, 1990; Tymianski and Tator, 1996) . Calcium has the potential to overactivate degradative enzyme ac tivities, including phospholipase, protease, and endo nuclease activities, which ultimately cause widespread destruction of membranes and macromolecules (Siesjo, 1994; Werling and Fiskum, 1996) and, therefore, result in relatively rapid necrosis. Reperfusion of ischemic tis sue can lead to swift reestablishment of Ca 2 + homeosta sis and potentially full recovery. However, ischemic al terations to mitochondrial oxidative phosphorylation, Ca 2 + sequestration, and free radical production can result in sufficient chronic or secondary metabolic failure, oxi dative stress, and altered cellular Ca 2 + levels so that se lectively vulnerable cells proceed toward some form of delayed death (Siesjo et aI., 1995) . Mitochondrial stress also can result in relatively subtle and reversible mito chondrial alterations that may specifically initiate the process of apoptosis without causing the level of meta bolic failure that would induce necrosis (Siesjo et aI., 1994) .
Effects of cerebral ischemia and reperfusion on mitochondrial activities
Brain mitochondria are comparatively sensitive to ischemic injury and even exhibit substantial impairment in respiratory and electron transport chain complex ac tivities after periods of moderately reduced cerebral blood flow, where there are no immediate changes in levels of ATP or phosphocreatine (Allen et aI., 1993 (Allen et aI., , 1995 . It is therefore possible that the partial ischemia present within the penumbra surrounding a focal infarct as well as the variable degree of ischemia present within the focus of a stroke can result in mitochondrial alter ations independent of the cellular energy state. The same argument also may apply to many areas of the forebrain that experience hypoperfusion for many hours after com plete global cerebral ischemia, such as that which occurs after cardiac arrest. In either scenario, it is possible that incomplete ischemia can result in greater mitochondrial injury than complete ischemia as a consequence of the generation of reactive oxygen species (ROS) that attack mitochondrial lipids, proteins, and DNA and promote Ca 2 + -induced mitochondrial dysfunction (Rehncrona et aI., 1979; Veitch et aI., 1992; Allen et aI., 1995) . In addition to brain mitochondria being sensitive to injury induced by incomplete ischemia, these organelles also exhibit rapid changes in electron transport and ion permeability characteristics within only a few minutes of complete cerebral ischemia. Mitochondrial injury in re sponse to complete ischemia can be categorized and is dependent on the length of the ischemic period (Sims, 1991) . In the first type of injury, which occurs after approximately 5 to 30 minutes of ischemia, depending on the animal model, maximal rates of respiration measured with isolated mitochondria or tissue homogenates are reduced by 25% to 75% (Ginsberg et aI., 1977; Rehn crona et aI., 1979; Hillered et aI., 1985; White et aI., 1985; Sims and Pulsinelli, 1987; Rosenthal et aI., 1987; Lee, 1992, 1993; Sun and Gilboe, 1994) . Periods of complete ischemia in the range of 5 to 20 J Cereb Blood Flow Metab, Vo/. 19. No. 4, 1999 minutes represent those most relevant to human cardiac arrest when it is followed by successful cardiopulmonary resuscitation. Longer periods of ischemia generally are more applicable to the conditions present during a stroke. Most mitochondrial alterations that occur within the first 10 to 20 minutes of complete ischemia are reversible within an hour or two of reperfusion (Rehncrona et aI., 1979; Sims and Pulsinelli, 1987; Rosenthal et aI., 1987; Sims, 1991) . However, the existence of these alterations during the critical, early period of reperfusion may con tribute to the induction of a cascade of events that ulti mately lead to one or more forms of delayed cell death or dysfunction and, consequently, neurologic impairment.
The second category of mitochondrial injury occurs during approximately 30 minutes to 2 hours of complete ischemia and probably is relevant to injury occurring in cells located within focal infarcts that undergo spontane ous reperfusion through vascular recanalization. This type of mitochondrial injury is represented by more ex tensive inhibition of electron transport throughout vari ous regions of the electron transport chain (Linn et aI., 1987) . Unlike the alterations observed after short periods of complete ischemia, the respiratory impairment during this type of injury usually is only partially reversible without pharmacologic intervention and often becomes significantly worse within a few hours of reperfusion.
The third category of mitochondrial injury is charac teristic of acute necrotic cell death in which prolonged periods of deenergization of approximately 2 hours or more cause generalized destruction to the structural and functional integrity of cellular membranes. All compo nents responsible for oxidative phosphorylation, includ ing the ATP synthase, are extensively damaged, and the inner membrane becomes so leaky to ions and molecules that an electrochemical gradient of protons sufficient to drive ATP synthesis and Ca 2 + uptake cannot be gener ated. Reperfusion after these extensive periods of com plete ischemia results in little improvement in mitochon drial activities and is not effective at reducing acute cell death. Nevertheless, some neuroprotective interventions may partially improve mitochondrial activities and re duce neuronal injury under these extreme conditions (Kuroda et aI., 1996a,b; Folbergrova et aI., 1995) . Such acute and mainly irreversible cell death may be appli cable to cells within the core of focal ischemic infarcts that are deprived of O 2 and glucose for several hours or more (Kuroda et aI., 1996a) . However, spontaneous reperfusion occurs even within the core of cerebral in farcts in humans after thromboembolytic stroke (Jor gensen et aI., 1994) and, therefore, most acute ischemic mitochondrial injury that occurs during human stroke, cardiac arrest, and head trauma likely falls within the first two categories. The fourth type of mitochondrial injury is character ized by reperfusion-dependent alterations. Depending on the duration and degree of ischemia, reperfusion may be accompanied by changes in the activity of specific elec tron transport chain components. As with acute ischemic injury, the flow of electrons through complex I is most sensitive to early, reperfusion-dependent inhibition after complete ischemia, although other complexes can be in volved to a lesser extent (Sims, 1991; Sciamanna and Lee, 1993; Almeida et aI., 1995) . Such injury also is exacerbated when reperfusion follows incomplete rather than complete ischemia (Rehncrona et aI., 1979) . Com plex IV (cytochrome oxidase [COX)) activity also de clines significantly after complete ischemia or anoxia plus one to several hours of reperfusion in some models (Wagner et aI., 1990; Nelson and Silverstein, 1994; Abe et aI., 1995) but not in others (Sims, 1991 , Canevari et aI., 1997 Zaidan and Sims, 1997) . Reperfusion periods of 24 hours or more result in additional generalized dam age to the mitochondrial electron transport chain (Sims, 1991) . Several laboratories describe an inhibition of the maximal activity of pyruvate dehydrogenase (PDH), a mitochondrial matrix enzyme, at periods of reperfusion of 30 minutes to 24 hours after 10 to 30 minutes of complete cerebral ischemia (Katayama and Welsh, 1989; Sims, 1993, 1997; Bogaert et aI., 1994; ) . The anatomical distribution of injury to PDH also corre sponds well with the spatial distribution of neuronal vul nerability to delayed death during ischemia and reperfu sion (Zaidan and Sims, 1993) .
In addition to the forms of mitochondrial injury ap parent with mitochondria isolated from brain samples after cerebral ischemia and reperfusion, other aspects of mitochondrial dysfunction are likely to exist in situ that are readily reversible and therefore not apparent once the tissue is processed and the mitochondria are isolated. For example, low tissue pH is known to inhibit respiration (Hillered et aI., 1984, see later) . It also is possible that other factors (e.g., the presence of free fatty acids and Ca 2 + accumulated within the mitochondrial matrix) re sult in additional mitochondrial respiratory inhibition and membrane leakiness that is not apparent once the mitochondria are isolated and these factors have been lost (Hillered and Chan, 1988) . The activity of COX in the brain after ischemiaireperfusion also may be grossly overestimated by O 2 electrode and spectrophotometric measurements performed in vitro because of the fact that nitric oxide exerts a readily reversible but potent com petitive inhibition with O 2 for one or more active sites in this complex (Brown, 1995; Giuffre et aI., 1996) . Since at least one form of nitric oxide synthase appears to be mitochondrially localized (Bates et aI., I 995a; Giulivi et aI., 1998) and the generation of nitric oxide is greatly accelerated in the reperfused brain (Samdani et aI., 1997) , this agent may limit the rate of postischemic ce rebral O 2 consumption, particularly in regions and at times when tissue O 2 concentrations are abnormally low from hypoperfusion (Bates et aI., 1995b) . Thus, the true degree of mitochondrial dysfunction within the brain is likely underestimated by measurements performed with mitochondria displaced from the extremely abnormal postischemic intracellular environment.
Consequences of mitochondrial injury
Consequences of mitochondrial injury after cerebral ischemia and reperfusion can be numerous and include metabolic failure, oxidative stress, exacerbation of exci totoxicity through impaired intracellular Ca 2 + buffering, and promotion of apoptosis through release of apopto genic factors such as cytochrome c (Fig. 1 ). There is considerable evidence that mitochondrial dysfunction can limit the return and continued maintenance of normal levels of ATP and other high-energy metabolites after both global and focal cerebral ischemia (Chang et aI., Kuroda et aI., 1996a; Siesjo et aI., 1995) . A decrease in the rate at which mi tochondria can generate A TP also may be responsible for the chronic postischemic tissue lactic acidosis observed in some models of ischemic brain injury (Rosenthal et aI., 1992) . Support for the possibility that inhibition of PDH is a least partially responsible for postischemic lac tate accumulation comes from observations demonstrat ing reduction of tissue lactate levels and improvement of neurologic outcome by administration of agents such as acetyIcarnitine and 1,3-butanediol, which have the po tential to generate acetyl coenzyme A, a product of the PDH reaction (Marie et al., 1987; Rosenthal et al., 1992; Gueldry and Bralet, 1994; Aureli et aI., 1994; Shuaib et aI., 1995) . The finding that brain pyridine nucleotides and electron transport chain components are hyperoxi dized for a substantial period during reperfusion also indicates that a primary metabolic defect resides at one or more reactions that generate NADH for use by the electron transport chain (Rosenthal et aI., 1995; Perez Pinzon et aI., 1997) . It remains to be established whether the degree of inhibition of the activity of PDH or any or the components of the electron transport chain is suffi cient to be responsible for postischemic metabolic de rangements and whether these relations specifically con tribute to the selective vulnerability of different neuronal subclasses to delayed postischemic death.
In addition to the influence that ischemic and post ischemic mitochondrial injury has on cerebral energy metabolism, mitochondrial alterations may significantly influence postischemic intracellular Ca2+ homeostasis. Because of the technical difficulties involved in measur ing intracellular Ca 2 + levels within the brain, the primary evidence for importance of mitochondrial Ca 2 + transport in determination of neuronal viability after reperfusion comes indirectly from studies reviewed in the March 1999 issue of Journal of Cerebral Blood Flow and Me tabolism (Murphy et aI., 1999) demonstrating the impor tance of mitochondrial Ca 2 + accumulation in excitotoxic death (see also Reynolds and Hastings, 1995 , Dugan et aI., 1995 , Ankarcrona et aI., 1995 , Budd and Nicholls, 1996 Stout et aI., 1998) . Mitochondrial sequestration clearly is taking place during reperfusion, since mito chondria isolated from reperfused brain contain higher loads of Ca 2 + (see later, Zaidan and Sims, 1994) . How ever, damage to mitochondria lowers the capacity for energy-dependent Ca 2 + sequestration by isolated brain mitochondria after as little as 10 minutes of global cere bral ischemia (Sciamanna et aI., 1992; Fiskum et al., 1997) . A 5-hour period of reperfusion after 30 minutes of forebrain ischemia in the rat also has been reported to greatly inhibit the ability of isolated mitochondria to ac tively accumulate and retain Ca 2 + (Sciamanna and Lee, 1993) . Whether this reduction in active Ca 2 + uptake and retention limits the rate and extent of normalization of J Cereb Blood Flow Metab. Vol. 19, No. 4, 1999 intracellular Ca2+ during cerebral reperfusion is un known. Regardless, this reduction in the ability to accu mulate supranormal levels of extramitochondrial Ca 2 + is associated with an increased sensitivity to Ca 2 +-induced respiratory inhibition and to Ca 2 + -stimulated release of the apoptotic factor cytochrome c (Fiskum et aI., 1997) .
Mitochondria are a primary source of ROS in normal, healthy tissue. Although mitochondria often are also pro claimed to be the primary generators of ROS during reperfusion, there are only a few key studies performed in vivo that support this hypothesis. Using microdialysis procedures, Piantadosi and Zhang (1996) demonstrated that cerebral cortex free radical production increases dur ing reperfusion and that addition of a complex I electron transport chain inhibitor substantially attenuates this el evation. Other evidence obtained with electron spin reso nance spectroscopy indicates that radicals are generated at the level of the electron transport chain component coenzyme Q during cerebral hypoxia and reoxygenation (Hasegawa et aI., 1993) . As with the potential for mito chondrial involvement in secondary metabolic failure and altered intracellular Ca 2 + levels, additional studies are needed to establish direct relations between mito chondrial free radical production and oxidative reperfu sion injury and to determine how such interactions relate to selective neuronal vulnerability to delayed death.
Mediators of mitochondrial injury
Several interrelated factors have been proposed to contribute to mitochondrial impairment after cerebral ischemia and reperfusion. These factors include low in tracellular pH, high levels of intracellular Ca 2 +, and oxi dative stress caused by elevated production of ROS. Since these are the same pathologic conditions that are exacerbated by mitochondrial dysfunction, a vicious cycle of subcellular injury and abnormal intracellular conditions can be generated ( Fig. 1) .
Lactic acidosis has long been considered as a mecha nism responsible for mitochondrial injury during cere bral ischemia. Support for this hypothesis has come from experiments in which increased mitochondrial respirato ry impairment has been associated with increased sys temic acidosis during the ischemic period (Rehncrona et aI., 1979) . These conditions were invoked by inducing incomplete ischemia rather than by completely eliminat ing cerebral blood flow. Since incomplete ischemia likely also promotes the generation of ROS, the exacer bation of mitochondrial injury may have been caused by increased oxidative stress rather than aggravated acido sis. Other studies demonstrate that hyperglycemia before complete cerebral ischemia exacerbates accumulation of brain lactate and prolongs the reperfusion time necessary for full recovery of mitochondrial respiratory character istics (Kim et aI., 1996; Hillered et aI., 1985) . Experi-ments performed with isolated brain mitochondria have clearly demonstrated that respiration is sensitive to inhi bition by acidosis, with state 3 O 2 consumption being inhibited by 70% at pH 6.1 compared with that observed at pH 7. 2 (Hillered et al., 1984) . Early, postischemic brain acidosis would therefore be expected to impair oxi dative phosphorylation and limit the rate at which the concentrations of high-energy phosphate-containing compounds return to normal; however, measurements of postischemic A TP and phosphocreatine levels have not supported this hypothesis (Hillered et aI., 1985) . Acidic pH also may affect other mitochondrial activities such as ROS production and Ca 2 + sequestration. Although under some circumstances acid pH reduces the maximal capac ity for mitochondrial Ca 2 + sequestration (Akerman, 1978) , low pH also may inhibit the mitochondrial mem brane permeability transition (Bernardi et al., 1992) . Be cause the disadvantages or advantages of mild acidosis during and after cerebral ischemia are controversial (Levine, 1993; LaManna et aI., 1995; Schurr et aI., 1997) , more information on the effects of pH on the normal and abnormal activities of brain mitochondria should be obtained.
Mitochondrial energy transduction is highly depen dent on membrane-linked oxidationlreduction reactions and ion transport activities. It is therefore not surprising that ischemic mitochondrial derangements have been as sociated with alterations to membrane lipids. Free fatty acids are released from phospholipids and accumulate rapidly in the brain after just a few minutes of cerebral ischemia (Bazan, 1970; Katsura et aI., 1993) . Several studies demonstrate that ischemic brain mitochondria specifically undergo phospholipid degradation and accu mulate free fatty acids and that such accumulation can be at least partially responsible for the respiratory impair ment evident after cerebral ischemia (Hillered and Chan, 1988; Nakahara, et aI., 1991; Sun and Gilboe, 1994a) . Moreover, postischemic normalization of brain mito chondrial lipids has been associated with normalization of mitochondrial respiration (Sun and Gilboe, 1994b) .
Mitochondrial lipids also are subject to oxidative modifications during cerebral ischemiaireperfusion. Brain mitochondrial malondialdehyde, an oxidized lipid degradation product, accumulates both during reperfu sion and during complete global ischemia (Sun and Gil boe, 1994a,b) . Substantial evidence points to membrane lipid oxidation as an important component of reperfusion brain injury (Traystman et al. 1991; Chan, 1996; Liu et aI., 1998) , although the degree to which mitochondrial lipid oxidation contributes to injury is unknown. Mito chondrial lipid oxidation can occur during ischemia alone and continues during reperfusion (Sun and Gilboe, 1994a) . Mitochondrial malondialdehyde levels are low ered by postischemic treatment of rats with platelet ac tivating factor antagonists (Sun and Gilboe, 1994b) . Also, the protection against reperfusion-dependent respi ratory impairment afforded by either preischemic or postischemic treatment of rats with the free radical scav enger ascorbate may be due to inhibition of mitochon drial lipid oxidation (Sciamanna and Lee, 1993) .
In addition to oxidative modification to lipids, indirect evidence indicates that certain mitochondrial proteins may be subject to oxidative injury. Bogaert and col leagues (1994) demonstrated that the activity of PDH is reduced during reperfusion in a model in which site specific brain protein oxidation occurs (Liu et aI., 1993) . Bogaert and coworkers (1994) and Tabatabaie and asso ciates (1996) also have demonstrated that this protein is particularly sensitive to oxidative inactivation. However, it remains to be established whether the mechanism re sponsible for the loss of this important enzyme activity in vivo is through oxidative injury, proteolysis, or other means. It is also possible that oxidative molecular alter ations are additionally responsible for injury to the elec tron transport chain. Exposure of isolated brain mito chondria to experimental conditions that generate super oxide and hydroxyl radicals results in patterns of respiratory injury similar to those observed in vivo (Hill ered and Ernster, 1983) . Specifically, state 3 respiration is dramatically inhibited with little or no increase in state 4 respiration, and the inhibition is more profound when NADH-Iinked substrates (e.g., malate) rather than FADH-linked substrates (e.g., succinate) are oxidized. Direct oxidation of electron transport proteins may occur during reperfusion but is less likely to happen after isch emia alone, since oxidation of brain proteins has only been detected after at least a few hours of reperfusion (Oliver et aI., 1990; Liu et al., 1993) . Mitochondrial pro teins may possibly undergo oxidative injury, including that resulting from sulfhydryl oxidation as a consequence of postischemic exposure to peroxynitrite, which is formed from a reaction between superoxide and nitric oxide (Radi et aI., 1991a) . Although isolated mitochon dria and mitochondria present within cultured neurons are sensitive to respiratory inhibition by peroxynitrite (Radi et aI., 1994) , the primary site of inhibition appears to be one or more of the components that catalyze suc cinate/cytochrome c oxidoreductase activity, whereas complex I electron transport activity is resistant to inac tivation by peroxynitrite (Bolanos et aI., 1994 (Bolanos et aI., , 1995 . Since complex I activity is substantially more sensitive than complex II and III to injury caused by global isch emia and reperfusion, peroxynitrite-mediated mitochon drial damage may be more relevant to prolonged focal cerebral ischemia in which substantial loss of succinate dehydrogenase activity has been observed (Kuroiwa et aI., 1994) . As previously indicated, inhibition of electron transport activities evident after both ischemia alone and after ischemiaireperfusion also could be an indirect con-sequence of mitochondrial membrane lipid oxidation (Soussi et al., 1990) , which can be catalyzed by peroxy nitrite (Radi et al., 1991b) .
Several lines of evidence suggest that Ca 2 + plays an important role in mitochondrial injury during cerebral ischemia and reperfusion. Preischemic treatment of ani mals with agents that either directly or indirectly inhibit cellular Ca 2 + influx results in substantial protection against mitochondrial respiratory impairment after 10 minutes of cardiac arrest (Rosenthal et al., 1987) . Ca 2 +_ induced injury during ischemia could occur by several different mechanisms, including stimulation of phospho lipid degradation through activation of phospholipases (Rordorf et al., 1991) or induction of proteolysis through activation of proteolytic enzymes such as calpains (Agu ilar et al., 1996) . Such mechanisms may respond directly to an increase in the cytosolic free Ca 2 + concentration or be initiated by mitochondrially accumulated Ca 2 +.
Since the driving force for mitochondrial Ca 2 + uptake is the respiration-generated membrane potential that ex ists across the inner membrane, the absence of O 2 during complete cerebral ischemia should severely limit mito chondrial Ca 2 + accumulation. Nevertheless, a small but significant time-dependent net accumulation of mito chondrial Ca 2 + occurs in complete cerebral ischemia (Sciamanna et al., 1992; Zaidan and Sims, 1994) . Sub stantially more Ca 2 + is found in brain mitochondria iso lated after only a few minutes of reperfusion (Zaidan and Sims, 1994) . These observations with isolated mitochon dria are supported by cytochemical staining procedures demonstrating early reperfusion-dependent mitochon drial calcium deposits that disappear within a few hours of reperfusion and reappear after 1 to 2 days of recircu lation (Hossmann et aI., 1985; Dux et al., 1987) . Sub stantial accumulation of calcium by brain mitochondria within the first few minutes of reperfusion would be expected, since electrophysiologic measurements of in traneuronal Ca 2 + indicate an increase in concentration from a baseline of less than 0.2 f.LM to greater than 30 f.LM in hippocampal neurons after 5 to 10 minutes of complete ischemia (Silver and Erecinska, 1990) .
During excessive reperfusion-dependent mitochon drial Ca 2 + sequestration, mitochondria may undergo re versible or irreversible damage by several different mechanisms. Reperfusion-dependent, Ca 2 + -mediated mi tochondrial injury can be described as "mitochondrial Ca 2 + overload" (Fig. 1) and may include the membrane permeability transition as well as molecular alterations that can be independent of mitochondrial swelling and insensitive to inhibitors of the permeability transition (e.g., cyclosporin A) (Murphy et aI., 1999) . Siesjo and colleagues suggest that mitochondrial Ca 2 + overload to gether with oxidative stress induce the permeability tran sition and bioenergetic failure after several hours of reperfusion (Siesjo et aI., 1995; Kuroda et al., 1996a;  J Cereb Blood Flow Metab. Vol. 19. No. 4. 1999 Folbergrova et aI., 1997). Although a delayed permeabil ity transition is consistent with the temporal course of delayed tissue and mitochondrial Ca 2 + accumulation and with some measures of mitochondrial respiratory impair ment, many of the intracellular conditions present during the first 10 to 30 minutes of reperfusion suggest that a transition could occur within this period. These condi tions include exposure of respiring mitochondria to high levels of Ca 2 + and abnormal levels of ROS in the pres ence of a relatively oxidized redox state of pyridine nucleotides (Silver and Ericinska, 1990; Eleff et al., 1991; Piantidosi and Zhang, 1996; Rosenthal et aI., 1995) . Mitochondrial Ca 2 + overload may also contribute to the release of cytochrome c and other apoptogenic factors from the miochondria into the cytosol (Fig. 1) , as observed after both focal and global cerebral ischemia (Fujimura et al., 1998; Perez-Pinzon et al., 1999) . As discussed in Murphy et al. (1999) , this Ca 2 + -induced phenomenon may be the consequence of the permeabil ity transition or due to the activation of a specific channel located in the mitochondrial outer membrane.
MITOCHONDRIA IN CHRONIC FORMS
OF NEURODEGENERA TION
Correlation of mitochondrial dysfunction with aging
Substantial evidence indicates that mitochondrial function declines with age. The fact that normal aging is the most reliable and robust risk factor for neurodegen erative diseases is likely beyond coincidence. It has been suggested that mitochondrial DNA (mtDNA) is both more susceptible to oxidative damage and is repaired less efficiently. Studies of hydrogen peroxide-treated human fibroblasts show threefold more damage to a fragment of mtDNA compared with a fragment of nDNA, and the damage was much more persistent (Yakes and Van Houten, 1997) . Numerous studies shown an age dependent accumulation of mtDNA deletions in both animals and man (reviewed in Beal, 1995) .
A critical issue is whether mtDNA deletions or point mutations have functional consequences. This was ad dressed in an elegant study of Laderman and colleagues (1996) . A novel technique pioneered by King and Attardi is to transfer mitochondria from patients to mtDNA deficient cells (pO cells) (King and Attardi, 1989) . Cell lines can be depleted of mtDNA by exposing them to low concentrations of ethidium bromide. Ethidium bromide is concentrated within mitochondria and intercalates into mtDNA at concentrations that inhibit replication of mi tochondrial but not nuclear DNA. Exposed cells assume an anaerobic phenotype and become auxotrophic for uri dine and pyruvate. Cybrids are formed by fusing mtDNA depleted cells with the platelets of enucleated cells (con taining mitochondria) of patients. Removal of uridine and pyruvate from the medium causes death of any un transformed cells and thus serves as a selection tool.
The resulting cybrids enable determination as to whether any defects in oxidative phosphorylation are at tributable to alterations in a patient's mtDNA, since the patient's mitochondria now function in the presence of a different nuclear genome. Laderman and colleagues took enucleated fibroblasts (containing mitochondria) of nor mal human individuals aged 20 weeks to 103 years and fused them with pO cells. The ensuing cybrid cell lines showed an age-dependent decrease in O 2 consumption. Although there was an age-dependent decrease in mtDNA content, this did not correlate with O 2 consump tion. These findings therefore support the notion that age-dependent accumulation of structural damage to the mitochondrial genome has functional consequences.
An interesting animal model of aging is that which occurs in prosimian primates (Schmechel et aI., 1996) . These animals show accelerated brain aging starting in early adulthood. They initially develop dystrophy of cho linergic axons and generalized gliosis at 10% of maximal life span, followed by extensive cerebral amyloidosis, which commences at 50% maximal life span. Conse quently, these animals represent a partial model for both accelerated aging and for AD. Studies show that these primates have mitochondrial abnormalities in both the heart and renal proximal tubules as early as 1 year of age. In cholinergic neurons, which show axonal dystrophy, there are both profiles of degenerating mitochondria as well as spheroids, which are immunoreactive for man ganese superoxide dismutase (SOD). Mitochondrial ab normalities occurred early and were closely associated with axonal dystrophy. These findings link mitochon drial dysfunction to both age-related axonal dystrophy and potentially to !3-amyloid deposition.
Mitochondria in Alzheimer's disease
Alzheimer's disease is the most common of the neu rodegenerative diseases. Advancing age is the most im portant risk factor, with a lO-fold increase in prevalence between ages 60 and 80 years, and a prevalence of 47% for patients older than age 85 years (Evans et aI., 1989). The essential clinical features are an early impairment of recent memory followed by progressive intellectual dys function. The pathologic hallmarks consist of deposition of amyloid in the form of senile plaques and the devel opment of neurofibrillary tangles. Familial AD is auto somal dominant and accounts for about 5% of all cases. These patients were found to have mutations in either the amyloid precursor protein or in novel proteins termed presenilins. Both of these genetic defects may be asso ciated with increased production of !3-amyloidl _4 2 , which shows an increased tendency to aggregate.
Most cases of AD, however, appear to be sporadic, although there is an increased incidence in families. If mitochondrial defects play a role in this form of AD, it would be expected that there would be evidence for ma-ternal inheritance, since the mitochondrial genome is in herited solely from the mother. Several studies suggest that this is the case. These studies show an increased female-to-male ratio of 3.6: 1 or 3.8: I in the parental generation of probands (Duara et aI., 1993; Edland et aI., 1996) . In 10 families with one affected parent and at least two affected siblings, the ratio of mothers to fathers was 9: 1 (Edland et aI., 1996) .
Evidence for metabolic deficits in AD comes from positron emission tomography (PET) studies, which show reduced glucose metabolism in the temporoparietal cortex. Changes occur early in the disease when there is minimal cognitive impairment. The PET studies also show increased O 2 utilization in comparison with glu cose utilization (Fukuyama et aI., 1994) . This finding was confirmed in studies of arteriovenous extraction of O 2 and glucose (Hoyer, 1993; Ogawa et aI., 1996) . The molar ratio of O 2 to glucose utilization in AD patients was 9.86 compared with 5.63 for seven age-matched controls. Abnormal glucose metabolism in brain biopsy specimens has been interpreted as partial uncoupling of mitochondria (Sims et aI., 1987) . Phosphorus magnetic resonance spectroscopy shows reduced phosphocreatine in cerebral cortex of mildly demented AD subjects (Pettegrew et aI., 1995) and increased inorganic phos phate (P) in frontal and temporoparietal cortex (Brown et aI., 1989) . In frontal cortex, the phosphocreatine inorganic phosphate ratio (PCr/Pi) was significantly re duced in AD compared with elderly controls (Smith et aI., 1995) . Other evidence for mitochondrial abnormali ties comes from ultrastructural studies, which show paracrystalline inclusions in AD mitochondria (Saraiva et aI., 1985) .
Studies of electron transport enzymes in AD show reduced complex IV activity. Parker and colleagues re port that complex IV activity was reduced in platelet mitochondria (Parker et aI., 1989) , which was disputed (Van Zuylen et aI., 1992) but confirmed in a follow-up study (Parker et aI., 1994) . In postmortem brain tissue, there is reduced complex IV gene expression and en zyme activity in frontal and temporal cortex (Kish et aI., 1992; Chandrasekaran et aI., 1996) . We found consistent reductions in complex IV activity in four cortical regions and no consistent alterations in the activities of com plexes J, II-III or V (Mutisya et aI., 1994) . A study of highly purified mitochondria from AD brain tissue shows reduced catalytic activity and perturbed enzyme kinetics, yet normal amounts of cytochrome aa3, the heme-containing component of complex IV (Parker et aI., 1994) . This suggests that reduced complex IV en zyme activity is a consequence of abnormal catalytic activity rather than decreased enzyme levels.
What is the source of the reduced complex IV activity in AD brain and platelets? It was demonstrated that COX defects can be transferred to cybrids from AD platelets and that the ensuing cybrid cell lines show increased free radical production (Davis et aI., 1997; Swerdlow et aI., 1997) . This suggests that a mtDNA defect results in de creased COX activity. Initial work suggests that point mutations in the COX] and COX2 genes segregate with most AD patients (Davis et aI., 1997) , but more recent evidence shows that the presumed mutations are poly morphisms in a nuclear pseudogene (Hirano et aI., 1997; Wallace et aI., 1997) . These polymorphisms therefore cannot be responsible for decreases in complex IV ac tivity in AD. The etiology of the defect in COX activity and mitochondrial function in AD cybrids therefore re quires further investigation.
Several other mtDNA mutations were reported in as sociation with AD. A ND2 mtDNA mutation in AD was found in one study (Lin et aI., 1992) ; however, this was not confirmed in two other studies (Kosel et aI., 1994; Petruzzella et aI., 1992) . Shoffner and colleagues found a mutation in nucleotide 4336 of the tRNA g in sequence in patients with AD and PD. The mutation was found in 5.2% of patients with AD-PD and in 0.7% of controls (Shoffner et aI., 1993) . This finding was confirmed in a follow-up study (Hutchin and Cortopassi, 1995) but dis puted in another (Wragg et aI., 1995) .
The consequences of COX defects in the cybrid cell lines on intracellular Ca 2 + buffering have been examined. The AD cybrids show elevated basal cytosolic Ca 2 + con centrations and enhanced sensitivity to inositol-l,4,5triphosphate-mediated Ca 2 + release, and they recover more slowly from the increased Ca 2 + levels (Sheehan et aI., 1997) . These findings are consistent with findings in AD fibroblasts (Gibson et aI., 1996; Huang et aI., 1991; Ito et aI., 1994) and with the finding of decreased Ca 2 + uptake in mitochondria from AD fibroblasts (Kumar et aI., 1994) . Impaired Ca 2 + buffering also is observed in fibroblasts from patients with mitochondrial encephalop athy lactic acidosis and strokes (MELAS) syndrome (Moudy et aI., 1995) .
If mitochondrial dysfunction truly plays a central role in the pathogenesis of AD, then an increase in oxidative damage might be expected as a consequence. Mitochon drial DNA would be expected to be particularly suscep tible, since it is located close to the inner mitochondrial membrane. Consistent with this possibility, there is a threefold increase in oxidative damage to mtDNA in postmortem tissue from AD patients compared with age matched controls (Mecocci et aI., 1994) . Other studies found increased concentrations of malondialdehyde and protein carbonyl groups and oxidative damage to nuclear DNA (reviewed in Beal, 1995; Lyras et aI., 1997) . Novel spin trapping techniques showed oxidative damage to both lipids and proteins (Hensley et aI., 1995) . There also is evidence for oxidative damage at a cellular level. Neu rofibrillary tangle-bearing neurons show immunostain ing with antibodies to advanced glycation end products, hemeoxygenase-l, malondialdehyde, 4-hydroxynonenal, protein carbonyl groups, carbonylated neurofilaments, and 3-nitrotyrosine (Smith et aI., 1995; Smith et aI., 1994; Smith et aI., 1996; Yan et aI., 1994; Schipper et aI., 1995; Premkumar et aI., 1995; Good et aI., 1996; Sayre et aI., 1997; Smith et aI., 1997) . Interestingly, these tech niques all show increased staining in cell bodies and neurites rather than senile plaques, suggesting an intra cellular source of free radicals.
Since the most consistent pathologic abnormality in AD is accumulation of amyloid in senile plaques, an important issue is whether impaired oxidative metabo lism can contribute to both I)-amyloid deposition and the generation of neurofibrillary tangles. Gabuzda and col leagues first showed that impairment of COX in vitro leads to an increase in c-terminal fragments of the amy loid precursor protein that contain the I)-amyloid peptide (Gabuzda et aI., 1994) . An increase in intracellular l)-amyloidl_4 2 was found after exposure of cultured guinea pig neurons to hydrogen peroxide (Ohyagi and Younkin, 1996) , and oxidative stress increased I)-amy loid in mammalian lenses (Frederikse et aI., 1996) . In creased accumulation of intracellular I)-amyloid also was observed in cultured astrocytes from patients with Down's syndrome, which have increased free radical production (Busciglio and Yankner, 1995) . Oxidative damage leads to cross-linking and impaired solubility of I)-amyloid, which may contribute to its deposition (Dyrks et aI., 1992; Dyrks et aI., 1993) . In vivo studies show that an impairment of oxidative metabolism pro duced by thiamine deficiency leads to an accumulation of amyloid precursor protein in abnormal neurites (Calingasan et aI., 1996; Calingasan et aI., 1995) . Oxi dative injury may contribute to the production of paired helical filaments, since oxidation of cysteine 322 on tau forms intermolecular cross-bridges, and this leads to gen eration of paired helical filaments in vitro (Schweers et aI., 1995) . Impaired ATP production also can activate the PK40 kinase, which can convert tau into a paired helical filament-like form (Roder and Ingram, 1991; Roder et aI., 1993) . These studies therefore suggest that energy impairment associated with COX deficiency could be responsible for amyloid deposition in AD.
Cell loss in AD, which may include apoptotic death (see Murphy et aI., 1999) , greatly exceeds the number of neurofibrillary tangles that accumulate, and more than 50% of the neurons are lost in the superior temporal gyrus (Gomez-Isla et aI., 1997). Mitochondrial dysfunc tion may contribute to this cell loss.
Mitochondria in Parkinson's disease
Much of the interest in the association of neurodegen eration with mitochondrial dysfunction and oxidative damage developed from studies of parkinsonism induced by I-methyl-4-phenyl-l,2,3,5-tetrahydropyridine (MPTP) (Bloem et aI., 1990) . This MPTP was inadver tently synthesized as a byproduct of synthesis of "de signer" opiates. It led to an outbreak of parkinsonism in southern California after injection by intravenous drug abusers. It was subsequently shown to produce parkin sonism in both mice and primates. The MPTP molecule is converted to I-methyl-4-phenylpyridinium (MPP+) by monoamine oxidase B. Then, MPP+ is taken up by the dopamine transporter and accumulates in mitochondria, where it inhibits complex I activity by binding reversibly to a site at or near the rotenone binding site. The MPP+ toxicity is associated with oxidative damage, since MPP+ induces superoxide formation and increases lipid peroxi dation.
The most consistent defect in oxidative phosphoryla tion in PD is reduced complex I activity (Beal, 1995) . In studies of PD brain tissue, complex I activity is reduced in the substantia nigra and is not altered in other brain regions. Three well-controlled studies show reduced complex I activity in PD platelets, including unmedi cated patients (Parker et aI., 1989; Benecke et a!., 1992; Haas et aI., 1995) . We found reduced coenzyme QlO levels in PD platelet mitochondria, which correlate with reduced complex I activity (Schults et aI., 1997) . A de crease in complex I activity also was reported in some studies of skeletal muscle and lymphocytes. Immuno staining for complex I subunits and for a-ketoglutarate dehydrogenase, a regulatory enzyme of the tricarboxylic acid cycle, is reduced in PD substantia nigra (Hattori et a!., 1991; Mizuno et a!., 1994) .
If a mtDNA defect plays a role in the pathogenesis of PD, it should be possible to identify evidence for mater nal inheritance. In five families in which a parent and multiple siblings had PD, the affected parent was the mother (Wooten et a!., 1997) . There also appeared to be an early age of onset in children of affected mothers. Several mtDNA point mutations were reported to be as sociated with PD, but this has not been confirmed (Luck ing et a!., 1995; Ozawa et aI., 1991) .
Mitochondrial complex I deficits from platelets of PD patients were expressed in cybrid cell lines, and the com plex I deficit was associated with increased free radical production, leading to apoptotic death (Swerdlow et aI., 1996; Gu et aI., 1998) . Furthermore, these cybrid cell lines showed increased vulnerability to MPP+, and the cell lines also have impaired Ca 2 + buffering (Sheehan et aI., 1997) . Other evidence of impaired oxidative phosphorylation in PD is decreased cortical and subcortical glucose me tabolism as assessed by PET, and increases in occipital lobe lactate using chemical shift magnetic resonance spectroscopy (Bowen et aI., 1995; Eberling et a!., 1994 ). An increase in basal ganglia lactate concentrations was found in 12 of 24 patients studied (Chen et aI., 1994). One study using phosphorus magnetic resonance spec-troscopy showed a decreased PCrIPi ratio in resting fore arm muscle of PD patients; however, this was not seen in other studies (Penn et aI., 1995; Taylor et aI., 1994) .
Direct evidence for oxidative damage in PD comes from studies showing elevations in both malondialde hyde and in cholesterol hydroperoxides (Dexter et aI., 1994) . Furthermore, concentrations of 8-0HdG are in creased threefold to fourfold in the caudate and substan tia nigra of PD patients (Sanchez-Ramos et aI., 1994) . Reduced concentrations of glutathione are found both in the substantia nigra of PD patients and in incidental Lewy body disease, which may be a presymptomatic phase of PD (Sofic et aI., 1992; Sian et ai., 1994; Dexter et aI., 1994) . Increased nitrosyl complexes were recently found in PD substantia nigra (Shergill et ai., 1996) . An immunohistochemical study shows increased 4-hy droxynonenal protein adducts, a marker of lipid peroxi dation, in PD substantia nigra neurons (Yoritaka et aI., 1996) and Lewy bodies stain with antibodies to hemeoxygenase-1 and glycation end products (Castellani et aI., 1996) .
Mitochondria and oxidative damage in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a prototypical neuro degenerative disease of late life characterized by pro gressive muscle weakness, atrophy, and spasticity, which ultimately leads to paralysis and death within 3 to 5 years (Brown, 1995) . The essential neuropathologic features consist of a loss of motor neurons in the anterior horns of the spinal cord, brain stem, and motor cortex. In the motor neurons, there are abnormal accumulations of neu rofilaments as well as proximal axonal swellings (Rou leau et ai., 1996) . Ninety percent of ALS cases are spo radic (SALS) with no identifiable genetic or environ mental risk factors. The remaining 10% of cases show familial inheritance, and one fourth of these are associ ated with missense mutations in the antioxidant enzyme copperlzinc superoxide dismutase (SOD1) (Rosen et aI., 1993) .
The observation that mutations in SOD cause familial ALS (FALS) suggests that a loss of function of this enzyme might lead to oxidative damage of the motor neuron. However, several factors argue that the disease arises from an adverse property of the mutant SODI protein. These include the dominant inheritance pattern in FALS; the lack of correlation between enzyme activity and disease severity (Bowling et aI., 1995) , and the ob servation that overexpression of the mutant enzyme in transgenic mice (which have increased SOD activity) leads to motor neuron degeneration (Gurney et aI., 1994; Ripps et aI., 1995; Wong et aI., 1995) . With rare excep tions, the mutations occur outside of the active site of the enzyme; all mutations that have been studied appear to alter the stability of the protein backbone and to reduce the half-life of the molecule (Borchelt et aI., 1994) . These changes may relax the conformation of the active channel, thereby allowing increased access of hydrogen peroxide or peroxynitrite to the active site copper. This is predicted to increase generation of hydroxyl radicals or nitronium ions, which can nitrate proteins (Beckman et aI., 1993) . In vitro studies show that SOD with two dif ferent FALS mutations generates hydroxyl radicals more readily than the wild-type molecule (Wiedau-Pazos et aI., 1996; Yim et aI., 1996) . We confirmed this in vivo using microdialysis in transgenic mice carrying the G93A mutation (Bogdanov et aI., 1998) .
Several studies suggest the involvement of energy me tabolism defects in the pathogenesis of SALS, including observations of reduced glucose metabolism in the cere bral cortex of SALS patients in PET studies (Hatazawa et aI., 1988; Dalakas et aI., 1987) . We found that complex I activity was significantly elevated by 55.3% in frontal cortex (Brodmann area 6) of familial ALS patients with the A4V SOD 1 mutation (Bowling et aI., 1993) . In motor cortex (Brodmann area 4), we found a significant in crease in complex I and II-III activities, whereas in pa rietal cortex there was an increase in complex I activity, and in cerebellum, complex II-III activity was increased (Browne et aI., 1998) . Interestingly, complex I activity also was significantly increased in cerebral cortex of transgenic mice with the G93A human SODI mutation. This mouse, as well as other mice with SOD l mutations, shows mitochondrial swelling and vacuolization as a prominent early pathologic feature (Gurney et aI., 1994; Wong et aI., 1995, Dal Canto and Gurney, 1994) . Fur thermore, an increase in mitochondrial vacuolization im mediately precedes a rapid phase of development of mo tor weakness (Kong and Xu, 1998) . There is no prece dent for increased electron transport activity in neurologic illnesses, and we can only speculate that this may be a compensatory phenomenon, perhaps for a dam aged inner mitochondrial membrane. Expression of the G93A SODI mutation in vitro leads to a decline in mi tochondrial membrane potential and sensitizes mitochon dria to depolarization produced by valinomycin (Carri et aI., 1997).
We did not find alterations in electron transport en zymes in SALS; however, it is still possible that subtle abnormalities may occur. If electron transport defects are heterogeneous among patients, it may not be possible to detect them in postmortem tissue because of an averag ing effect. Peripheral blood lymphocytes from SALS pa tients show increased cytosolic Ca 2 + and altered re sponses to uncouplers of oxidative phosphorylation (Curti et ai., 1996) . Ultrastructural studies of mitochon dria of anterior horn cells from both FALS patients and SALS patients show mitochondrial abnormalities (Hi rano 1991; Sasaki et aI., 1990; Sasaki and Iwata, 1996) . Liver biopsy specimens show large mitochondria and J Cereb Blood Flow Metab, Vol. 19, No. 4, 1999 intramitochondrial inclusions in SALS patients (Masui et aI., 1985) . Mitochondria with abnormal protrusions were observed in a F ALS patient who was later determined to have an SODI mutation (Hirano, 1991) . Studies of muscle biopsy specimens of SALS patients showed in creased mitochondrial volume and Ca 2 + levels (Siklos et aI., 1996) .
Mitochondrial dysfunction could contribute to the pathogenesis of both FALS and SALS by leading to increased free radical production and oxidative damage. Furthermore, it could contribute to slowed axonal trans port, leading to the accumulation of neurofilaments, which have been observed in both SALS and F ALS (Rouleau et ai., 1996; Sasaki and Iwata, 1996; Shibata et ai., 1996) . Studies of motor neurons in SALS patients show an accumulation of mitochondria in proximal axons, consistent with impaired axonal transport (Sasaki and Iwata, 1996) .
Studies of oxidative damage show increased protein carbonyl groups in the motor cortex and spinal cord of sporadic ALS patients (Bowling et aI., 1993; Shaw et aI., 1995) . We measured concentrations of 3-nitrotyrosine and its major metabolite, 3-nitro-4-hydroxy-phenylacetic acid, in the thoracic and lumbar spinal cord of both spo radic ALS patients and three FALS patients with SODI mutations (Beal et aI., 1997) . Increased concentrations of both 3-nitrotyrosine and 3-nitro-4-hydroxyphenylacetic acid were found in both the sporadic and the F ALS pa tients. We also examined whether there was evidence for increased oxidative damage at the cellular level using antibodies to 3-nitrotyrosine, hemeoxygenase-l, and malondialdehyde. Both the sporadic and the familial ALS patients showed increased staining in anterior horn motor neurons (Ferrante et aI., 1997) .
Mitochondria in Huntington's disease
Huntington's disease is an autosomal dominant inher ited neurodegenerative illness characterized by both a movement disorder and dementia. The pathologic hall mark is a degeneration of the basal ganglia and, to a lesser extent, cerebral cortex. Interestingly, the patholog ic process within the basal ganglia is highly selective, with interneurons, such as those containing the histo chemical marker NADPH-diaphorase, being spared. The genetic defect in the illness has been elucidated as being an expansion of a CAG trinucleotide repeat sequence in a gene whose protein product was designated huntingtin. How the gene defect leads to neuronal degeneration re mains obscure. The CAG repeats in the huntingtin pro tein are expressed, leading to an expanded stretch of glutamines within the protein. The mRNA for huntingtin is widely expressed in the CNS, without pronounced re gional differences; however, the protein is preferentially expressed in the medium-sized spiny projection neurons of the basal ganglia and cortical pyramidal projection neurons that degenerate in HD (Ferrante et aI., 1997) .
Several studies using PET showed reduced glucose metabolism in the basal ganglia of HD patients (re viewed in Beal, 1995) . Using proton magnetic resonance spectroscopy, we found elevated lactate concentrations in both occipital cortex and in the basal ganglia of symp tomatic HD patients (Jenkins et aI., 1993) . Some asymp tomatic gene carriers also show elevated lactate in the basal ganglia (Jenkins et aI., 1998) . The increased lactate concentrations correlate well with the duration of dis ease, implying that normal energy metabolism is pro gressively impaired by the disease process. An increase in lactate in frontal and occipital cortex and cerebellum was reported by others (Harms et aI., 1997; Martin et aI., 1996) . We found a decrease in the PCr/Pi ratio in resting gastrocnemius muscle of HD patients, providing evi dence for a systemic defect in energy metabolism (Koro shetz et aI., 1997) . This observation is consistent with reports of progressive weight loss in HD patients despite increased caloric intake (O'Brien et aI., 1990) . The CSF measurements show an increased lactate-pyruvate ratio in HD patients (Koroshetz et aI., 1997) .
Several studies have examined oxidative phosphory lation enzymes in postmortem brain tissue. Reduced suc cinate dehydrogenase activity was found in two studies (Butterworth et aI., 1985; Stahl and Swanson, 1974) . A recent study showed a 55% to 60% decrease in com plexes II and III activities in HD caudate, and a 33% decrease in complex IV activity (Gu et aI., 1996) . We found that complex II-III activity was reduced by 29% in the caudate and 67% in the putamen, but unaffected else where (Browne et aI., 1997) . Complex IV also was re duced 62% in the putamen. Complex I activity and ci trate synthase activities showed no changes. The most consistent biochemical enzymatic defects in HD there fore appear to involve succinate dehydrogenase and complex II-III activity (of which succinate dehydroge nase is a component) of the electron transport chain. This is of interest, since we found that systemic administration of complex II-III inhibitor 3-nitropropionic acid pro duces striatal lesions in rats and primates that closely mimic HD (Beal et aI., 1993; Brouillet et aI., 1995) . Furthermore, an inherited defect in succinate dehydroge nase is associated with basal ganglia degeneration (Bourgeron et aI., 1995) .
Studies of cultured fibroblasts from HD and control subjects are consistent with a mitochondrial defect. Greenamyre and colleagues examined the consequences of Ca 2 + influx induced by ionomycin on mitochondrial membrane potential (Gutekunst et aI., 1996) . Normal fi broblasts show depolarization and recovery, but HD fi broblasts show a failure to recover fully after the second application of ionomycin. One proposed mechanism by which the HD gene de-fect could lead to impaired energy metabolism is by an interaction with glyceraldehyde-3-phosphate dehydroge nase (GAPDH). Huntingtin binds with high affinity to GAPDH, a critical component of the glycolytic pathway that catalyzes the oxidation and phosphorylation of glyc eraldehyde 3-phosphate to 1,3-bisphosphoglycerate (Burke et aI., 1996) . Furthermore, both GAPDH and a-ketoglutarate dehydrogenase can be inactivated by trans glutaminase when pathologic increases in polyglu tamine repeats are present in vitro (Cooper et aI., 1997) . Intrastriatal administration of the GAPDH inhibitor io doacetate produces dose-dependent striatal excitotoxic lesions, which correlate with inhibition of enzyme activ ity (Matthews et aI ., 1997a) . However, spectrophotomet ric assays of GAPDH activity failed to detect differences between HD and control postmortem brain samples (Browne et aI., 1997) . Few studies explore oxidative damage in HD. In HD caudate, there was a significant 21 % increase of 8-0HdG in nuclear DNA (Browne et aI., 1997) . A sufficient amount of mtDNA for measurements was available only in cerebral cortex and cerebellum. In parietal cortex, there was a twofold significant increase in 8-0HdG in mtDNA (Polidori and Beal, unpublished findings). There were increased mtDNA deletions in HD cerebral cortex (Horton et aI., 1995) , although this was not found in another study (Chen et aI., 1995) . In preliminary studies, there was increased staining of HD striatal neurons with antibodies to hemeoxygenase-l, 8-0HdG, and malondi aldehyde-modified protein (Ferrante et aI., 1996) .
There is evidence for a metabolic defect in a trans genic model of HD. Transgenic mice were made by ex pressing numerous CAG repeats (130 to 140) in exon I of the HD gene (Mangiarini et aI., 1996) . The mice de velop normally for about 8 weeks followed by onset of a movement disorder with tremors and subsequent sei zures. The mice die at about 12 weeks of age. Neuro pathologic examination shows small brains, although there does not appear to be basal ganglia degeneration. Notice that the animals show a progressive weight loss starting at 8 weeks of age despite an apparently increased caloric intake. This is consistent with increased caloric expenditure, which occurs in HD patients (O' Brien et aI., 1990) .
Other neurologic diseases
Several neurodegenerative diseases other than HD are associated with an expanded CAG trinucleotide repeat, suggesting that there may be common pathologic mecha nisms in all of these diseases. In several of these, there is evidence for metabolic defects. In spinocerebellar ataxia I, there are reduced levels of a-ketoglutarate dehydro genase in postmortem tissue (Mastrogiacomo et aI., 1996) . In spinocerebellar ataxia 2, muscle biopsy speci mens show areas devoid of mitochondria or with focal G. F1SKUM ET AL.
accumulations and autophagic vacuoles, which may con tain mitochondria (Forsgren et aI., 1996) . In spinocer ebellar ataxia 3 (Machado-Joseph Disease), CSF lactate/ pyruvate is reported to be elevated (Matsuishi et aI., 1996) . Overexpression of a portion of this gene contain ing the CAG repeat leads to apoptotic cell death in cul tured neurons and to Purkinje cell degeneration in trans genic mice (Ikeda et aI., 1996) .
Friedrich's ataxia is autosomal recessive and evidence suggests a loss of function. Evidence shows that the Frie drich's ataxia protein, frataxin, has a mitochondrial lo calization (Babcock et aI., 1997) . The homologous gene in yeast regulates mitochondrial iron transport, and its dysfunction leads to accumulation of mitochondrial iron and oxidative damage (Babcock et aI., 1997; Priller et aI., 1997) . In postmortem tissue, a-ketoglutarate dehydroge nase levels are reduced (Mastrogiacomo et aI., 1996) . Endomyocardial biopsy specimens show reduced com plex I, complex II-III, and aconitase activities, consistent with oxidative damage to iron-sulphur clusters (Rotig et aI., 1997) . Wilson's disease may involve a similar mechanism, since the disease-associated gene encodes a copper-transporting P-type ATPase that was recently lo calized to mitochondria (Lutsenko and Cooper, 1998) . A defect in platelet complex I activity was found in idio pathic dystonia (Benecke et aI., 1992; Schapira et aI., 1997) . Patients with Leber's optic atrophy with dystonia, which is caused by point mutations in the ND 6 subunit of complex I (Jun et aI., 1994) , develop progressive basal ganglia degeneration (Bruyn et aI., 1992; Novotny et aI., 1986) . Another neurodegenerative disease that recently has been shown to caused by mitochondrial impairment is hereditary spastic paraplegia (Casari et aI., 1998) . This disease was shown to be caused by either a deletion or point mutations in a protein termed paraplegia, which is a mitochondrial metalloprotease. Patients show ragged red fibers and bizarre mitochondrial morphologic fea tures in muscle biopsy specimens.
THERAPEUTIC CONSEQUENCES
A novel therapeutic strategy for either acute or chronic neurodegeneration is to use compounds to improve mi tochondrial metabolism to compensate for injury or dis ease-related defects. As described earlier, acetyl-L camitine provides neuroprotection after cerebral isch emia by a mechanism that appears to compensate for reperfusion injury to the mitochondrial PDH enzyme (Rosenthal et a!., 1992; Bogaert et aI., 1994) . Other pu tative neuroprotective agents may have direct or indirect effects on mitochondrial oxidative phosphorylation. The electron transport chain component coenzyme Q IO ' or Ubiquinone, is a potent antioxidant that protects against glutamate toxicity in vitro (Favit et a!., 1992) . It produces dose-dependent protection against striatal lesions pro-duced by the succinate dehydrogenase inhibitor malo nate, and it protects against malonate-induced A TP depletions (Beal et aI., 1994) . It also protects against both MPTP and 3-nitropropionic acid neurotoxicity, and it extends survival in the transgenic mouse model of FALS (Matthews et aI., 1998a) . In HD patients, oral adminis tration results in significant decreases in occipital cortex lactate concentrations, which reverse after withdrawal of therapy (Koroshetz et aI., 1997) . Coenzyme QI O exerts additive effects with N-methyl-D-aspartate antagonists against malonate lesions (Schulz et aI., 1996) . This has led to a proposal to test coenzyme Q I O and an N-methyl D-aspartate antagonist both alone and in combination in the treatment of HD. Another approach that we recently examined is to use creatine administration to increase phosphocreatine levels and thereby buffer against energy depletion. Oral administration protects against striatal le sions produced by both malonate and 3-nitropropionic acid (Matthews et aI., 1998a) . Furthermore, we showed that it protects against phosphocreatine and A TP deple tions as well as increases in 3-nitrotyrosine concentra tions, which we believe, occur downstream of energy depletion.
As discussed, there is substantial evidence that oxida tive damage occurs in acute and chronic neurodegenera tive diseases, which may be a consequence of mitochon drial dysfunction. This suggests that free radical scaven gers may be effective. Free radical spin traps attenuate malonate, 3-nitropropionic acid, and MPTP neurotoxic ity (Schulz et aI., 1996) . A critical mediator of oxidative damage may be peroxynitrite, which is generated by the reaction of nitric oxide with superoxide radical (0 2 -), Mitochondrial dysfunction leads to increased peroxyni trite by increasing mitochondrial O 2 -generation and by raising cytosolic Ca 2 + levels, which then activates neu ronal nitric oxide synthase. 7-Nitroindazole, a relatively selective neuronal nitric oxide synthase inhibitor, dose dependently blocks MPTP neurotoxicity, and it protects against malonate and 3-nitropropionic acid neurotoxicity (Schulz et aI., 1995a,b) . Mice that are deficient in neu ronal nitric oxide synthase are resistant to MPTP toxicity (Przedborski et aI., 1996) , and S-methyl-thiocitrulline, another relatively selective neuronal nitric oxide syn thase inhibitor, also protects against MPTP neurotoxicity in mice (Matthews et aI., 1997 b) . 7-Nitroindazole pro duced protection against dopamine depletion, loss of substantia nigra neurons, and motor and cognitive defi cits induced by MPTP in baboons (Hantraye et aI., 1996) .
Other antioxidants, such as those present in extracts from the Ginkgo Biloba tree, also have been purported to pro tect against indices of oxidative injury in mitochondria from the brains of old animals (Sastre et aI., 1998) . Other potential agents for use in amelioration of acute and chronic neurodegeneration include neurotrophic fac tors, which can be effective in animal models involving mitochondrial dysfunction (Kirschner et aI., 1996) , and nonimmunosuppressive agents, which target the mito chondrial PTP to attempt to block its potential contribu tion to necrotic and apoptotic death. Current data suggest that strategies designed to improve mitochondrial respi ratory function, decrease ROS production, and inhibit mitochondrial apoptogen release might all prove to be useful in the treatment of neurodegenerative diseases as sociated with mitochondrial dysfunction. 
